What we're reading

Press

Stay updated with the latest insights and discoveries in therapeutic innovation.
BetaGlue® renews the BoD: Dr Colin Story appointed CEO
Colin Story - BetaGlue

BetaGlue® renews the BoD: Dr Colin Story appointed CEO

The Board of Directors welcomes new Board Members Giovanni Cerutti and Luca Melindo who will support the company's future growth The Ordinary Shareholder’s Meeting of BetaGlue Technologies appointed the new Board of Directors: Colin Story, Giovanni Cerutti and Luca Melindo have been appointed Directors of the Company, while Diana Saraceni, Claudio Giuliano, Michel Therin are…

1201 801 Betaglue® Therapeutics
  • 1
  • 2